搜索筛选:
搜索耗时4.9235秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[会议论文] 作者:Liang Dong,Mina Zhang,Yuelang Zeng, 来源:第六届亚洲特大城市环境与公共健康论坛暨中国环境科学学会环境医学与健康分会2015年会 年份:2015
  Health is a state of complete physical, mental, and social well-being, and not merely the absence of disease or infirmity (WHO).Health issues include water...
[会议论文] 作者:Yuanyuan Niu,Huijuan Wang,Zhiyong Ma,Jie Ma,Guowei Zhang,Mina Zhang, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: KRAS mutation was a poor prognostic factor in NSCLC, the patients with KRAS-MT has shorter survival than those of KRAS-WT.So it is urgentto further investigate the role of KRAS pathway and...
[会议论文] 作者:Huijuan wang,Ziqi Wang,Haixia Li,Xuanxuan Zheng,Guowei Zhang,Mina Zhang,Xiaojuan Zhang,Zhiyong Ma, 来源:2019中国肿瘤学大会 年份:2019
Objective Brain metastasis is a cause of disease progression and death in lung cancer patients,and is also one of the most common metastatic sites of lung cancer....
[会议论文] 作者:Wang Huijuan,Zhang Mina,Zhang guo Wei,Zhu Hui,Wang Qiming,Li Peng,Yan Xiangtao,Li Shaomei,Ma Zhi Yong, 来源:第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份:2013
[会议论文] 作者:Wang Huijuan,Zhang Mina,Zhang guo Wei,Zhu Hui,Wang Qiming,Li Peng,Yan Xiangtao,Li Shaomei,Ma Zhi Yong, 来源:第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份:2013
Background: As one of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI),gefitinib has been proven to be highly effective for patients with advanced NSCLC.However, almost all pa...
相关搜索: